Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Vasodialators Oil-composition

 Solid oral dosage forms of ifosfamide
OF PREFERRED EMBODIMENTS The invention is illustrated by the following examples: EXAMPLE 1 I...


 [(benzodioxan, benzofuran or benzopyran) alkylamino] alkyl substituted guanidines
We claim: 1. A compound of the formula: ##STR259## a pharmaceutically acceptable acid addition salt ...


 Methods for treating dermatitis using descarboethoxyloratadine
OF THE INVENTION The present invention encompasses a method of treating allergic asthma in a human ...


 Fat emulsions containing isocarbacyclin
What is claimed is: 1. A pharmaceutical prostaglandin emulsion comprising: a mixture of vegetable ...


 Dermal pharmaceutical preparations
OF THE INVENTION The support which can be used in the present invention functions to retain a ...


 Substituted iminodiacids, their preparation and pharmaceutical compositions containing them
We claim: 1. A compound selected from the group consisting of iminodiacid compounds having the ...


 2-Azasfiro[4.(3+N)]-3-carboxylic acid derivatives, a process for their preparation, agents containing these derivatives and their use
We claim: 1. A compound of the formula I ##STR11## in which n denotes 1, 2, 3 or 4, R denotes (C....


 N-Acyl hexahydroindole-2-carboxylic acids and anti-hypertensive use thereof
We claim: 1. A compound of the formula I, ##STR24## in which n denotes 0 to 1, R denotes hydrogen, (...


 Bicyclic amino acids as intermediates in the preparation of tricyclic amino acids and processes for their preparation
We claim: 1. A compound of the formula III ##STR19## in which A denotes --CH.dbd.CH-- or --CH.sub.2 ...


 Substituted N-carboxymethyl-aminoacylaminoalkanoic acids useful as antihypertensive agents
OF THE INVENTION AND PREFERRED EMBODIMENTS In its broadest aspect, the present invention relates ...


 Oil composition

Details
Inventors: Koike, Shin; Hosoya, Naoki; Yasumasu, Takeshi;
Assignee: Kao Corporation (Tokyo, JP)
Primary Examiner: Weddington; Kevin E.
Assistant Examiner:
Attorney, Agent or Firm: Oblon, Spivak, McClelland, Maier & Neustadt, P.C.

The invention relates to oil composition comprising 0.1 to 59.8% by weight of a triglyceride, 40 to 99.7% by weight of a diglyceride, 0.1 to 10% by weight of a monoglyceride and at most 5% by weight of a free fatty acid, wherein contents of .omega.3 type unsaturated acyl groups having at least 20 carbon atoms and monoenoic acyl groups in acyl groups constituting the diglyceride are 15 to 89.5% by weight and 10 to 84.5% by weight, respectively; and oral medicinal compositions and foods comprising such an oil composition. The oil composition effectively develops physiological functions derived from .omega.3 type unsaturated fatty acids, such as inhibition of platelet aggregation, and is excellent in effect of facilitating combustion of body fat, oxidation stability, flavor and the like, and also excellent in flowability.

DETAILED DESCRIPTION What is claimed is: 1.
An oil composition, comprising about 0.
1 to 59.
8% by weight of a triglyceride, about 40 to 99.
7% by weight of a diglyceride, about 0.
1 to 10% by weight of a monoglyceride, and at most about 5% by weight of a free fatty acid, wherein a content of .
omega.
3 unsaturated acyl groups having at least 20 carbon atoms and monoenoic acyl groups in acyl groups consisting the diglyceride are about 15 to 89.
5% by weight and about 10 to 84.
5% by weight, respectively.
2.
The oil composition of claim 1, which further comprises 0.
1 to 10% by weight of a glyceride polymer.
3.
The oil composition of claim 1, wherein a content of .
omega.
6 unsaturated acyl groups in acyl groups consisting the diglyceride is 0.
5 to 75% by weight.
4.
The oil composition of claim 1, wherein the triglyceride comprises 8 to 24 carbon atoms in acyl groups consisting the triglyceride.
5.
The oil composition of claim 4, wherein the triglyceride comprises 16 to 22 carbon atoms in acyl groups consisting the triglyceride.
6.
The oil composition of claim 1, wherein said triglyceride contains at least 55% of unsaturated acyl groups based upon all acyl groups present.
7.
The oil composition of claim 6, wherein said triglyceride contains at least 70% of unsaturated acyl groups based upon all acyl groups present.
8.
The oil composition of claim 7, wherein said triglyceride contains at least 90% of unsaturated acyl groups based upon all acyl groups present.
9.
The oil composition of claim 1, wherein said triglyceride is obtained from a vegetable oil, animal oil, fractionated oil or random transesterified oil thereof.
10.
The oil composition of claim 1, wherein said acyl groups comprising the diglyceride comprises said .
omega.
3 unsaturated acyl groups in an amount of 20 to 70% by weight, and said monoenoic acyl groups in an amount of 12 to 45%.
11.
The oil composition of claim 10, wherein said acyl groups comprising the diglyceride comprise said .
omega.
3 unsaturated acyl groups in an amount of 25 to 65% by weight, and said monoenoic acyl groups in an amount of 12 to 35%



Related patents
  Blocking agents of EDRF effect or formation for the treatment of shock
We claim: 1. A therapeutical composition of matter for the treatment by perfusion of shock states comprising as an essential ingredient therein an effective amount of a ...
  Use of polyamines as ionic-channel regulating agents
OF THE PREFERRED EMBODIMENTS The disclosure of any and all cited documents including literature and patent application is incorporated by reference in its entirety. It ...
  Inhibitor of ceramidase
It is a general object of the invention to provide a method of selecting compounds that cause intracellular accumulation of ceramide. It is a specific object of the ...
  Treatment of bone disorders with adrenomedullin
OF THE INVENTION It is believed that one skilled in the art can, based on the description herein, utilize the present invention to its fullest extent. The following ...
  99MTC(III) myocardial imaging agents and method of use
OF THE INVENTION The technetium compounds of the present invention which have been found most useful as myocardial imaging agents in humans comprise hexadentate ...
  1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents
OF THE INVENTION Compounds of the formula I may be prepared as illustrated in the following reaction scheme. ##STR6## Referring to the above reaction scheme, compounds ...
  Vaginal sponge delivery system
These and other objects of the invention are achieved in a product which broadly comprises (a) a sealed, air-tight package, enclosing therein (b) a sponge impregnated ...
  Controlled release formulation
What is claimed is: 1. In a controlled release angiotensin converting enzyme inhibitor formulation in the form of an uncoated tablet from which upon ingestion ...
  Formulations providing three distinct releases
We claim: 1. A therapeutic composition for oral administration consisting essentially of a pharmaceutical gelatin capsule containing film coated spheroids, which ...
  Floating sustained release therapeutic compositions
OF THE INVENTION According to the present invention, therapeutic dosage forms have now been discovered which are easy to prepare, provide sustained release of contained ...

0.004

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved